ArticleOncoimmunology2024

High circulating HMGB1 indicates good prognosis in patients with advanced leiomyosarcoma under chemoimmunotherapy.

Lucillia Bezu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.